Patent · US Active

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

US9957301B2 · kind B2 · utility

1Cited by
6References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 24, 2015
Grant dateMay 1, 2018
Priority date—
Expiry dateJul 1, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y406/01001
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a kit of parts, suitable for use in a therapy of cancer, wherein said kit comprises:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.